According to the proteomics, although the expression of TOP2A was also reduced for this comparison, there were multiple other changes in the DNA damage recognition/repair machinery that affected the overall outcome (e.g., reduction in breast cancer gene 2, BRCA2 [37] and gain in PARP1 [38]; Table 1). The gene discussed is BRCA2; the disease is cancer.